| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/02/2008 | EP1872794A1 Nasal vaccine |
| 01/02/2008 | EP1872793A1 Polyamino acid for use as adjuvant |
| 01/02/2008 | EP1872792A1 A method for the production of hydrolyzed allergen |
| 01/02/2008 | EP1872791A1 Use of bacterial polysaccharides for biofilm inhibition |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1871888A2 Haemophilus influenzae type b |
| 01/02/2008 | EP1871885A1 Materials and methods for respiratory disease control in canines |
| 01/02/2008 | EP1871884A2 Porcine circovirus and helicobacter combination vaccines |
| 01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 01/02/2008 | EP1871810A2 Conjugated anti-psma antibodies |
| 01/02/2008 | EP1871804A2 Reagents that bind ccx-ckr2 |
| 01/02/2008 | EP1871803A1 Stabilized anti-hepatitis b (hbv) antibody formulations |
| 01/02/2008 | EP1871800A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists |
| 01/02/2008 | EP1871484A2 Sema4d in cancer diagnosis, detection and treatment |
| 01/02/2008 | EP1871419A2 Methods of treating graft versus host disease |
| 01/02/2008 | EP1871418A2 Humanized anti-cd70 binding agents and uses thereof |
| 01/02/2008 | EP1871417A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/02/2008 | EP1871416A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 01/02/2008 | EP1871415A2 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof |
| 01/02/2008 | EP1871414A1 Method for traeting inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/02/2008 | EP1871413A2 Minor allergen control to increase safety of immunotherapy |
| 01/02/2008 | EP1871412A2 Soluble vox2 protein as immunoregulatory factor |
| 01/02/2008 | EP1871411A2 Expressing hepatitis b virus surface antigen for vaccine preparation |
| 01/02/2008 | EP1871410A2 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
| 01/02/2008 | EP1871409A2 Improved method and apparatus for treating bacterial infections in devices |
| 01/02/2008 | EP1871405A2 Use of rip in treating staphylococcus aureus infections |
| 01/02/2008 | EP1871391A2 Endogenous retrovirus and proteins encoded by env as a target for cancer treatment |
| 01/02/2008 | EP1871375A2 Carboline derivatives useful in the treatment of cancer |
| 01/02/2008 | EP1871171A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 01/02/2008 | EP1871166A2 Cancer vaccines and therapeutic methods |
| 01/02/2008 | EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 01/02/2008 | EP1458410B1 Process for preparation of a mRNA tumour antigen library |
| 01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
| 01/02/2008 | EP1381380B1 Pharmaceutical composition containing bulbophyllum |
| 01/02/2008 | EP1227929B1 Colloidal rod particles as nanobar codes |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
| 01/02/2008 | EP1005365B1 Epitopes of an extracellular antigen |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | EP0722499B1 Immunoreactive antigens of hepatitis e virus |
| 01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098892A Antibodies against IL-13 receptor alpha 1 and uses thereof |
| 01/02/2008 | CN101098712A Domantis ltd (gb) |
| 01/02/2008 | CN101098711A Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine |
| 01/02/2008 | CN101098710A Sars vaccines and methods to produce highly potent antibodies |
| 01/02/2008 | CN101096656A Helicobacter pylori recombinant VacA monoclonal antibody and uses thereof |
| 01/02/2008 | CN101096384A Preparation method of fused protein for antitumor and application thereof |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101095953A Treating cancer through attracting effect T cell and loss regulating T cell |
| 01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 01/02/2008 | CN101095951A Therapeutic HBV DNA vaccines, method for preparing the same and application thereof |
| 01/02/2008 | CN101095950A Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof |
| 01/02/2008 | CN101095949A Shigellae oil-emulsion inactivated vaccine and the developing method thereof |
| 01/02/2008 | CN100359327C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100359001C Compartmentalization of recombinant polypeptides in host cells |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314924 Polynucleotide encoding a genetically engineered P30 antigen |
| 01/01/2008 | US7314922 Cutaneous T-cell lymphoma associated genes; expression in malignant tumors and in ordinary testis tissue, diagnosis and therapy of tumoral diseases |
| 01/01/2008 | US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli |
| 01/01/2008 | US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314734 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/01/2008 | US7314721 Autologous antibody screening; indication of regression, progression or onset |
| 01/01/2008 | US7314715 Recombinant avian herpesvirus useful in vaccine production |
| 01/01/2008 | US7314632 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/01/2008 | US7314631 Chimeric viral particle for use as tool in the prevention and treatment of bacterial and viral disease in humans |
| 01/01/2008 | US7314630 Peptides reactive with antibodies formed against oncoproteins of the human papillomavirus; diagnostic immunoassay |
| 01/01/2008 | US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection |
| 01/01/2008 | US7314628 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 01/01/2008 | US7314624 Emulsion comprising an aqueous phase, an oil phase, and a solvent and an immunogen |
| 01/01/2008 | US7314623 Methods and compositions for modulating T helper (Th) cell development and function |
| 01/01/2008 | US7314622 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/01/2008 | US7314621 Gene ecodeing protein; activation; cloning; DNA libraries from rodents |
| 01/01/2008 | US7314620 Methods for diagnosis and treatment of PH domain signal transduction disorders |
| 01/01/2008 | US7314619 Polypeptide for use in the treatment of cancer |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 12/27/2007 | WO2007150077A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 12/27/2007 | WO2007150008A2 Polypeptides from african swine virus as vaccines for preventive and therapeutic use |
| 12/27/2007 | WO2007149935A2 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 12/27/2007 | WO2007149875A2 Compositions and methods for treating, preventing and/or reversing type-1 diabetes |
| 12/27/2007 | WO2007149814A1 Methods of modulating il-22 and il-17 |
| 12/27/2007 | WO2007149802A2 Formulation for delivery of immune response modifiers |
| 12/27/2007 | WO2007149715A2 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
| 12/27/2007 | WO2007149586A2 Anti-c35 antibodies for treating cancer |
| 12/27/2007 | WO2007149566A2 Viral sequences and uses thereof |
| 12/27/2007 | WO2007149491A2 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 12/27/2007 | WO2007149490A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins |